Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-30

Clinical Trial Update: Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AM001 Cream for actinic keratosis has completed, reporting on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AM001 Cream

Snippet

Sponsor: AmDerma | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED